【结 构 式】 |
【分子编号】58403 【品名】N-((1S)-1-{[((1S,2S)-3-{[(1S)-2-amino-1-(4-bromobenzyl)-2-oxoethyl]amino}-1-benzyl-2-hydroxypropyl)amino]carbonyl}-2-methylpropyl)-2-pyridinecarboxamide 【CA登记号】 |
【 分 子 式 】C30H36BrN5O4 【 分 子 量 】610.55114 【元素组成】C 59.02% H 5.94% Br 13.09% N 11.47% O 10.48% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(XI)The N-carbobenzoxy group of (X) is then removed by treatment with triflic acid, yielding (XI). Finally, Suzuki coupling of the aryl bromide (XI) with phenylboronic acid leads to the title biphenyl derivative.
【1】 Noteberg, D.; et al.; New antimalarials: Design and synthesis of protease inhibitors with effect in cultured parasite-infected human erythrocytes. Drugs Fut 2002, 27, Suppl. A. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(X) | 58401 | benzyl (1S)-2-amino-1-(4-bromobenzyl)-2-oxoethyl[(2S,3S)-2-hydroxy-3-({(2S)-3-methyl-2-[(2-pyridinylcarbonyl)amino]butanoyl}amino)-4-phenylbutyl]carbamate | C38H42BrN5O6 | 详情 | 详情 | |
(XI) | 58403 | N-((1S)-1-{[((1S,2S)-3-{[(1S)-2-amino-1-(4-bromobenzyl)-2-oxoethyl]amino}-1-benzyl-2-hydroxypropyl)amino]carbonyl}-2-methylpropyl)-2-pyridinecarboxamide | C30H36BrN5O4 | 详情 | 详情 |
Extended Information